Literature DB >> 10845827

Mild renal failure is associated with adverse outcome after cardiac valve surgery.

R J Anderson1, M O'Brien, S MaWhinney, C B VillaNueva, T E Moritz, G K Sethi, W G Henderson, K E Hammermeister, F L Grover, A L Shroyer.   

Abstract

The present study was performed to ascertain whether the presence of mild renal failure (defined as a serum creatinine concentration of 1. 5 to 3.0 mg/dL) is an independent risk factor for adverse outcome after cardiac valve surgery. An extensive set of preoperative and postoperative data was collected in 834 prospectively evaluated patients undergoing cardiac valve surgery at 14 Veterans Affairs Medical Centers. Univariate and multivariable analyses were performed to determine whether an independent association of mild renal dysfunction with adverse outcomes was present. Patients with mild renal failure had significantly greater 30-day mortality rates (P = 0.001; 16% versus 6%) and frequency of postoperative bleeding (P = 0.023; 16% versus 8%), respiratory complications (P = 0.02, 29% versus 16%), and cardiac complications (P = 0.002; 18% versus 7%) than patients with normal renal function (serum creatinine <1.5 mg/dL) when controlling for multiple other variables. The presence of a serum creatinine concentration of 1.5 to 3.0 mg/dL is significantly and independently associated with adverse outcomes after cardiac valve surgery.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10845827     DOI: 10.1016/s0272-6386(00)70050-3

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  8 in total

1.  Cardiac catheterization within 24 hours of valve surgery is significantly associated with acute renal failure.

Authors:  Sara A Hennessy; Damien J LaPar; George J Stukenborg; Matthew L Stone; Ryan A Mlynarek; John A Kern; Gorav Ailawadi; Irving L Kron
Journal:  J Thorac Cardiovasc Surg       Date:  2010-09-15       Impact factor: 5.209

2.  Predictive Accuracy of a Perioperative Laboratory Test-Based Prediction Model for Moderate to Severe Acute Kidney Injury After Cardiac Surgery.

Authors:  Sevag Demirjian; C Allen Bashour; Andrew Shaw; Jesse D Schold; James Simon; David Anthony; Edward Soltesz; Crystal A Gadegbeku
Journal:  JAMA       Date:  2022-03-08       Impact factor: 157.335

3.  Correlation of the EuroSCORE with the onset of postoperative acute kidney injury in cardiac surgery.

Authors:  Edmilson Bastos de Moura; Saint-Clair Gomes Bernardes Neto; Fábio Ferreira Amorim; Renato Camargo Viscardi
Journal:  Rev Bras Ter Intensiva       Date:  2013 Jul-Sep

4.  Does the preoperative mild renal dysfunction effect mortality and morbidity following valve cardiac surgery?

Authors:  Hadi Abo Aljadayel; Hussein AlKanj; Salah Koja; Fadi Butruss
Journal:  Indian Heart J       Date:  2016-01-14

5.  Model for end-stage liver disease predicts mortality for tricuspid valve surgery.

Authors:  Gorav Ailawadi; Damien J Lapar; Brian R Swenson; Suzanne A Siefert; Christine Lau; John A Kern; Benjamin B Peeler; Keith E Littlewood; Irving L Kron
Journal:  Ann Thorac Surg       Date:  2009-05       Impact factor: 4.330

6.  Late Survival After Aortic Valve Replacement in Patients With Moderately Reduced Kidney Function.

Authors:  Natalie Glaser; Veronica Jackson; Martin J Holzmann; Anders Franco-Cereceda; Ulrik Sartipy
Journal:  J Am Heart Assoc       Date:  2016-12-17       Impact factor: 5.501

7.  COMT-Val158Met-polymorphism is not a risk factor for acute kidney injury after cardiac surgery.

Authors:  Matthias Kornek; Marcus-André Deutsch; Stefan Eichhorn; Harald Lahm; Stefan Wagenpfeil; Markus Krane; Ruediger Lange; Johannes Boehm
Journal:  Dis Markers       Date:  2013-08-07       Impact factor: 3.434

8.  Impact of Transcatheter Aortic Valve Implantation on Kidney Function.

Authors:  Rita Calça; Rui C Teles; Patrícia Branco; Augusta Gaspar; João Brito; Tiago Nolasco; Manuel D Almeida; José P Neves; Miguel Mendes; Domingos S Machado; André Weigert
Journal:  Arq Bras Cardiol       Date:  2019-12       Impact factor: 2.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.